These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 21194565)

  • 1. Role of nuclear receptors for bile acid metabolism, bile secretion, cholestasis, and gallstone disease.
    Claudel T; Zollner G; Wagner M; Trauner M
    Biochim Biophys Acta; 2011 Aug; 1812(8):867-78. PubMed ID: 21194565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting nuclear bile acid receptors for liver disease.
    Trauner M; Baghdasaryan A; Claudel T; Fickert P; Halilbasic E; Moustafa T; Zollner G
    Dig Dis; 2011; 29(1):98-102. PubMed ID: 21691114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional regulation of hepatobiliary transport systems in health and disease: implications for a rationale approach to the treatment of intrahepatic cholestasis.
    Wagner M; Trauner M
    Ann Hepatol; 2005; 4(2):77-99. PubMed ID: 16010241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New molecular insights into the mechanisms of cholestasis.
    Wagner M; Zollner G; Trauner M
    J Hepatol; 2009 Sep; 51(3):565-80. PubMed ID: 19595470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear receptor regulation of the adaptive response of bile acid transporters in cholestasis.
    Wagner M; Zollner G; Trauner M
    Semin Liver Dis; 2010 May; 30(2):160-77. PubMed ID: 20422498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear receptors in acute and chronic cholestasis.
    Gonzalez-Sanchez E; Firrincieli D; Housset C; Chignard N
    Dig Dis; 2015; 33(3):357-66. PubMed ID: 26045270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular regulation of hepatobiliary transport systems: clinical implications for understanding and treating cholestasis.
    Trauner M; Wagner M; Fickert P; Zollner G
    J Clin Gastroenterol; 2005 Apr; 39(4 Suppl 2):S111-24. PubMed ID: 15758646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear receptor-driven alterations in bile acid and lipid metabolic pathways during gestation.
    Papacleovoulou G; Abu-Hayyeh S; Williamson C
    Biochim Biophys Acta; 2011 Aug; 1812(8):879-87. PubMed ID: 21073948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms of cholestasis.
    Zollner G; Trauner M
    Wien Med Wochenschr; 2006 Jul; 156(13-14):380-5. PubMed ID: 16937039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular bile salt transport: lessons from cholestasis.
    Trauner M; Fickert P; Stauber RE
    Can J Gastroenterol; 2000 Nov; 14 Suppl D():99D-104D. PubMed ID: 11110621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of farnesoid X receptor in cholestasis.
    Yuan ZQ; Li KW
    J Dig Dis; 2016 Aug; 17(8):501-509. PubMed ID: 27383832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholestasis-induced bile acid elevates estrogen level via farnesoid X receptor-mediated suppression of the estrogen sulfotransferase SULT1E1.
    Liu X; Xue R; Yang C; Gu J; Chen S; Zhang S
    J Biol Chem; 2018 Aug; 293(33):12759-12769. PubMed ID: 29929982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of inflammation in cholestasis: clinical and basic aspects.
    Kosters A; Karpen SJ
    Semin Liver Dis; 2010 May; 30(2):186-94. PubMed ID: 20422500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear receptors as therapeutic targets in cholestatic liver diseases.
    Zollner G; Trauner M
    Br J Pharmacol; 2009 Jan; 156(1):7-27. PubMed ID: 19133988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bile Acid Metabolism and Signaling in Cholestasis, Inflammation, and Cancer.
    Li T; Apte U
    Adv Pharmacol; 2015; 74():263-302. PubMed ID: 26233910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear receptors: mediators and modifiers of inflammation-induced cholestasis.
    Mulder J; Karpen SJ; Tietge UJ; Kuipers F
    Front Biosci (Landmark Ed); 2009 Jan; 14(7):2599-630. PubMed ID: 19273222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bile acid transporters and regulatory nuclear receptors in the liver and beyond.
    Halilbasic E; Claudel T; Trauner M
    J Hepatol; 2013 Jan; 58(1):155-68. PubMed ID: 22885388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations.
    Zollner G; Marschall HU; Wagner M; Trauner M
    Mol Pharm; 2006; 3(3):231-51. PubMed ID: 16749856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epistane, an anabolic steroid used for recreational purposes, causes cholestasis with elevated levels of cholic acid conjugates, by upregulating bile acid synthesis (CYP8B1) and cross-talking with nuclear receptors in human hepatocytes.
    Petrov PD; Fernández-Murga L; Conde I; Martínez-Sena T; Guzmán C; Castell JV; Jover R
    Arch Toxicol; 2020 Feb; 94(2):589-607. PubMed ID: 31894354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New perspectives for the treatment of cholestasis: lessons from basic science applied clinically.
    Boyer JL
    J Hepatol; 2007 Mar; 46(3):365-71. PubMed ID: 17223219
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.